The
Ethics of Exponential Life Extension through
Brain Preservation Michael A.
Cerullo Brain
Preservation Foundation Cincinnati.psychiatry@gmail.com
Journal of
Evolution and Technology - Vol. 26
Issue 1 – March 2016 - pgs 94-105
Abstract Chemical brain preservation allows the
brain to be preserved for millennia. In the coming decades, the information in
a chemically preserved brain may be able to be decoded and emulated in a
computer. I first examine the history of brain preservation and recent advances
that indicate this may soon be a real possibility. I then argue that chemical
brain preservation should be viewed as a life-saving medical procedure. Any
technology that significantly extends the human life span faces many potential
criticisms. However, standard medical ethics entails that individuals should
have the autonomy to choose chemical brain preservation. Only if the harm to
society caused by brain preservation and future emulation greatly outweighed
any potential benefit would it be ethically acceptable to refuse individuals
this medical intervention. Since no such harm exists, it is ethical for
individuals to choose chemical brain preservation. Introduction One essential
part of the definition of life is the drive to preserve existence. Thus it is
not surprising that life extension has been a key concern of humanity throughout
recorded history (Cave 2012). In the recent past, extending the human life span
beyond the ŇnaturalÓ limit was seen as selfish, dangerous, and immoral
(Fukuyama 2002; Kass 2003; PresidentŐs Council on
Bioethics 2003; Pijnenburg and Leget
2006; Blow 2013). However, a new generation of ethicists and scientists has
challenged these views and shown that arguments against life extension do not
hold up well to serious scrutiny (Bostrom 2005a; Bostrom 2005b; de Grey 2005; Horrobin
2005; Cutas and Harris 2007; Moen 2015). There is
also a growing component of the general public with renewed faith in the
progress of technology who are challenging traditional
views of aging (Bostrom 2006; Cave 2012). Together
these two trends suggest that society may be more accepting of revolutionary
approaches to life extension. The rapid advance of these technologies also
makes it imperative to engage in a serious ethical discussion before they are
implemented. In the late
1980s, two visionary thinkers – Drexler (1987) and Olson (1988) – simultaneously
proposed the hypothesis of chemical brain preservation. To understand chemical
brain preservation we need to begin with cryonics. The idea of cryonics
(freezing the body and brain) to suspend life until treatment can be provided
has been around for at least a few hundred years (Cave 2012).1
However, modern cryonics is based on a more sophisticated understanding of
death. In the past, death was defined as cardiac arrest (cessation of a
heartbeat), but modern resuscitation techniques have made this definition
outdated. The current medical definition of death is based on the cessation of
electrical activity in the cerebral cortex (National Conference of
Commissioners on Uniform State Laws 1980; Whetstine
et al. 2005). This definition is itself quickly becoming outdated with
improvements in neurology and neurosurgery (Thomson 2014). In his discussion of
cryonics, Merkle states: If the structures in the brain that
encode memory and personality have been so disrupted that it is no longer
possible in principle to recover them, then the person is dead. (1992, 9) This is known
as the information-theoretic definition of death and appears to be the ultimate
definition of irreversible death. It provides the theoretical basis of
cryonics: preserving the information in the brain until a time when the
personŐs injuries are able to be treated. Thus
cryonics is meant to be a life-saving medical procedure. The main limitation of
current cryonics is that it is uncertain whether the information in the brain is
truly preserved. This is at least partly due to the unjustified abandonment of
cryonics by the scientific community.2 Lack of funding is preventing
the research needed to improve the protocols and fund electron microscopy
studies needed to examine the integrity of the brain after preservation.
Nonetheless, there is indirect evidence that cryonics as currently practiced
may preserve the information in the brain which could then be theoretically
recovered. Meon (2015) has convincingly argued that
even if the chances of success are low, cryonics is still a rational choice
that individuals should be allowed to make. Now we are ready to return to the
proposals of Drexler and Olson. Chemical brain preservation as life
extension Drexler (1987)
and Olson (1988) showed that, when the information-theoretic definition of
death is accepted, cryonics is only one of many techniques of life extension by
information preservation. In chemical brain preservation, rather than using low
temperatures to lock the brain in place, the brain is placed in stasis by
chemical bonding (Drexler 1987; Olson 1988). This is known as plastination (Knott et al. 2008; Hayworth 2012).3 The current protocols for chemical brain
preservation were developed to preserve tissues for electron microscopy and
they continue to improve (Palay et al. 1962; Olson
1988; Knott et al. 2008; Hayworth 2012; Mikula and Denk 2015). Electron microscopy
requires tissues to be cut extremely thin, and thus requires strong chemical
bonding to avoid the breakup of tissue. Chemical preservation involves first
infusing the vascular system with paraformaldehyde and glutaraldehyde,
which fixes cellular proteins in place and prevents degradation. Next, lipids
are fixed in place by infusing the tissue with osmium tetroxide, and finally
the tissue is immersed in a plastic resin (Palay et
al. 1962; Hayworth 2012). Once this procedure is complete the tissue is essentially
embedded in plastic and completely preserved (think of insects trapped in
amber). Electron microscopy studies have demonstrated that plastination
does a remarkable job of preserving the brain (Knott et al. 2008; Hayworth
2012). In fact, modern chemical preservation does such a good job preserving
the cellular and molecular structure that life can truly be frozen in this
state. The tissue can be stored at room temperature without degradation and
presumably could be preserved intact for millions of years. The main limitation
of current brain preservation protocols is that they are limited to only a
small section of the brain (Hayworth 2012). However, the protocols are rapidly
advancing and there is an incentive price to scale up the preservation protocols
to allow the chemical preservation of a large mammalian brain (Hayworth 2012;
Brain Preservation Foundation – Tech Prize n.d.;
Brain Preservation Foundation – Announcement n.d.).
Starting in
the mid-nineteenth century, systematic brain lesion studies have convincingly
shown that the brain is completely responsible for the mind. The last two
decades have seen a revolution in our understanding of how this is achieved. It
turns out that identity is completely defined by anatomy: that is, brain connectivity
(Sporns, Tononi, and Ktter 2005; Hayworth 2012; Yang, Pan, and Gan 2009; Honey, Thivierge, and Sporns 2010; Seung 2011; Seung 2013). Our memories and personalities are captured in
the synaptic and dendritic connections in the brain, what is referred to as the
connectome. The connectome
contains all the information that matters for identity and consciousness
connectivity (Sporns, Tononi,
and Ktter 2005; Hayworth 2012; Yang, Pan, and Gan 2009; Honey, Thivierge, and Sporns 2010; Seung 2011; Seung 2013). Each night the specific electrical impulses
that generate the stream of consciousness stop and you are stored as physical
structure! The connectome reboots the stream of
consciousness each morning and identity continues. Cases of revival after
hypothermia (which is also now intentionally induced in trauma patients and
stops all electrical activity in the brain) counter arguments that there is
always some low level of consciousness, occurring even during deep sleep, that is
required for identity to continue (Bolte et al. 1988;
Thomson 2014). These cases also challenge the often
unarticulated assumption that some kind of continual material or
electrical circulation is required for identity to continue. Together the
information theory of death and our new understanding of the connectome imply that death does not occur until the
information in the connectome is irreversibly lost. Suppose that
chemical brain preservation is successful in preserving the connectome.
In the past it was pure speculation that somehow preserved brains could be
resuscitated using unknown nano-technology: In the distant future (e.g., 100
centuries from now), technology may advance to the state where the information
of an individualŐs brain design can be extracted from his or her preserved
brain and implanted in a new machine – the new brain of the individual. (Olson 1988, 79) It is a testament to the exponential growth of technology
that in contrast to OlsonŐs prediction of 100 centuries, the technology now
exists to extract the information from a preserved brain. It turns out that not
only is electron microscopy a key tool to verify the preservation of the connectome, it is also a key part of the technology for
extracting the information. The
best current methods of brain mapping involve scanning thin slices of a
chemically preserved brain with an electron microscope. Standard resolution is
around 50 nm when the slices are created with a diamond knife (Hayat 2000).
However, the newer technique of Focused Ion
Beam Scanning Electron Microscopy (FIBSEM) is able to scan tissue at
resolutions approaching 5 nm (Hayworth 2012; Hayworth 2015). The detail of all
the synaptic and dendritic connections and their strengths can be captured at a
resolution between 40 and 10 nm (Knott et al. 2008; Hayworth 2012). Even if the
details at the molecular level (neurotransmitter and
receptor levels) were necessary, this information is stored in the
chemically preserved brain and there is ongoing research and a variety of
promising techniques in development that can likely provide molecular level
scanning resolution (Sandberg and Bostrom 2008). Continued
progress in automated brain mapping techniques should allow the complete connectome to be obtained from preserved brains (Mishchenko 2009; Jain et al. 2010). The next key
piece of technology in making chemical brain preservation a life-saving
procedure is whole brain emulation (WBE) (also known as mind uploading). WBE
involves replicating the informational structure of the brain in software that
could then be run in a computer (Sandberg and Bostrom
2008; Eth, Foust, and Whale 2013; Sandberg 2013). WBE is now big science (Markram 2006; Van
Horn and Toga 2014; Human Brain Project n.d.). Knowledge of the connectome should allow for a complete emulation of brain
function, and the technologies for mapping the connectome
and for WBE have been advancing rapidly (Denk and Horstmann 2004; Markram 2006; Mishchenko 2009; Jain et al. 2010; Eliasmith
et al. 2012; Zador et al. 2012; Helmstaedter
et al. 2013; Yook, Druckmann, and
Kim 2013). The development of WBE and the computer technology to
implement it is now a flagship science initiative of the European Union known
as the Human Brain Project (Human Brain
Project n.d.). This project aims to develop a
complete emulation of a mouse brain within five years (Human Brain Project SP1 n.d.). Other than scale, there is no in-principle
difference involved in human WBE. The Human Brain Project aims to scan and
upload a significant portion of the human brain within ten years (Human Brain
Project SP2 n.d.). Estimates vary, but we may be
within 50 years of human WBE (Kurzweil 2005; Eth,
Foust, and Whale 2013; Sandberg 2013). One important concern remains: will
brain preservation followed by WBE preserve identity or even consciousness?
These philosophical questions are outside the main scope of this paper, but
there are good arguments that WBE does preserve identity and consciousness
(Lewis 1976; Parfit 1984; Gallois
2005–2011; Hayworth 2010; Wiley 2014; Cerullo
2015). Brain preservation and the individual Before talking
about the ethical arguments for or against brain perseveration we need to clear
up some confusion in terminology. The terms radical or extreme life extension
have been used in the past to describe a major increase in the human lifespan
(Blow 2013; Masci 2013; Samuel 2013). These terms are
unsatisfactory as they may have a negative connotation for many people.
Considerable life extension is another proposed term (Rantanen 2013). While lacking the negative
connotation of the previous terms it seems too vague; after all, some would
consider five years of life extension considerable. Therefore, I propose the
term exponential life extension. Exponential life extension can be defined as
increases in life expectancy and/or life span by 50 per cent or more. Any
discussion of exponential life extension also needs to touch on the common
mistake of equating this with immortality (de Grey 2005; Horrobin 2005; Cave 2012). Immortality
is a mythological concept and is not something that can be achieved with current
life extension technologies (Horrobin 2005).
Therefore, discussions of immortality are premature at this point and only
serve as a distraction from the debate regarding more credible life extension
technologies. Now we can
examine the ethical implications of brain preservation. First we will look at
the ethical issues involving the individual, and in the next section we will
examine arguments from a societal perspective. Is it ethically acceptable for
an individual to chemically preserve their brain? Currently this isnŐt even a
possibility, so we can rephrase this question as whether it is ethical for an
individual to preserve their brain in the future when this becomes possible. A
related question is whether it is ethical for individuals to research, and
support research on, brain preservation. I will assume
for this discussion that the protocol used for brain preservation has been
shown to preserve the connectome through clinical
trials on human brains under realistic scenarios (i.e. the protocol starting
minutes or more after brain death). We can also assume that the individual who
chooses brain preservation is convinced that brain preservation followed by WBE
will allow for the continuation of personal identity and consciousness. In this
case, the individual correctly views brain preservation as a life-saving
medical procedure. The option to choose (assuming a reasonable use of
resources) or refuse medical procedures is a fundamental right of current
medical ethics (Beauchamp and Childress 1977; Ad Hoc Committee on Medical
Ethics, American College of Physicians 1984). Thus the default position should
be to allow people to choose chemical brain preservation. To refuse to allow a
person to choose this procedure would be a major affront to the principle of
autonomy. The autonomy to choose brain preservation extends to the right to
pursue and fund research into brain preservation. Standard medical ethics
suggest that only evidence of serious harm to society could override a personŐs
autonomy to pursue chemical brain preservation (Beauchamp and Childress 1977;
Ad Hoc Committee on Medical Ethics, American College of Physicians 1984).
Therefore, we need to examine arguments that brain preservation could be
harmful to society, and this will be the focus of the next section. Brain preservation and society Medical ethics
clearly supports a personŐs right to have or refuse a medical procedure that is
deemed scientifically sound. Thus we need to examine what potential harms brain
preservation could have on society and determine whether these harms are enough
to override a personŐs autonomy. The greatest ethical challenges to brain
preservation concern issues of justice: will everyone be allowed to access
these technologies or will they be only for the rich? One worry is that society
will be dominated by a new oligarchy of those rich enough to afford brain
preservation. However, this scenario seems very unlikely. The procedure to
chemically preserve the brain is relatively straightforward and unlikely to
cost more than a minor medical procedure (cost is in fact part of the
requirement to win the brain preservation prize (Brain Preservation Foundation
– Tech Prize n.d.)). The goal of those working
on brain preservation is to have it recognized as a legitimate medical procedure
that should be covered by both public and private insurance. The second step of
WBE will likely be much more expensive. Yet WBE is an information technology
that should follow the economics of scale. A good parallel is the history of
the human genome project, another information technology. To sequence the first
genome took 13 years and 3 billion dollars to complete (Gitlin 2013). However, gene sequencing
technology gets cheaper every year and it may soon be possible to sequence
individual genomes for a few hundred dollars (Metzker
2010; Mardis 2011; Gitlin 2013; Raj 2014). There will likely be a time, early in the
development of the technology, when the cost of WBE will be too great for most
people. Yet the early pioneers will help reduce the cost of WBE. Time is one
thing those chemically preserved have plenty of, and
they can wait for the economics of scale to reduce costs. A
related concern about the justice of brain preservation is the worry about
limited resources. Is it right for people to continue to live past the ŇnormalÓ
life expectancy and take up resources that may not be available for the young?
First, it should be noted that brain preservation could also be used on the
young who would otherwise have died early. In this case, it is hard to see why the
genetic lottery is a better way to decide who lives 20 years and who lives 90
years. Yet it is true that most people will likely be older when they choose
brain preservation and there is a concern that there will a population explosion
if the human life span is increased (Singer 1991; Kevles
1999; Kass 2001; Glannon
2002). To a large extent these are open empirical questions. The world
population is slowing, and the industrialized nations (including China, Europe,
and Japan)4 are facing severe population
decline (Wilson 2004; Morgan and Taylor
2006; Zhavoronkov 2013). In fact, there may be a
major economic crisis looming due to the rapid decrease in population of these
nations, and this will likely be true of the rest of the world as it increases
in development (Rae et al. 2010; Zhavoronkov 2013). Rapid
advances in life-extension technology may, indeed, be needed to help the aging
population continue to be productive (Rae et al. 2010; Zhavoronkov
2013). Thus
brain preservation and WBE, rather than being a drain on society, may be part
of keeping future economies viable. Even if population trends change, society
can always choose to delay the revival of preserved brains until such time as
economic conditions allow. If these conditions never arrive, the outcome for
the individual is no worse than not choosing brain preservation in the first
place and anyone pursuing brain preservation should understand these risks. It
is also worth mentioning that those revived with WBE need not take up any
significant resources or space: if necessary, WBEs could be run in underground
computing facilities in a location that allows cheap solar power (e.g. unwanted
space in a desert). Another
concern is that there will be undue pressure on people to choose brain
preservation. First, it is important to recognize that those developing the
technology for brain preservation take it as fundamental that people have a
right to refuse such procedures (this is ingrained in the Brain Preservation
Foundation Bill of Preservation Rights (Brain Preservation Foundation –
Our Vision n.d.). There is no reason to suppose that
if brain preservation were allowed society would lose all respect for the
autonomy and freedom of medical consent that we have now. There is still a
legitimate worry that if brain preservation became widespread then many people
would indeed feel great, though informal, pressure to choose this option. We
can safely assume this will not be a concern early on, based on the limited
number of people who have pursued cryonics. As more evidence builds up that
brain preservation and WBE do preserve identity (i.e. as it is shown that WBE
of larger mammals captures behavior), more people will likely choose brain
preservation. When the first human is successfully emulated and reports being
the same person, most people will likely recognize brain preservation as
preserving identity (Kurzweil 2005). At this point,
people may indeed feel pressure from family and friends to also sign up for
brain preservation when they die. However, most of the pressure will arise
because people believe the technology works, and this can hardly be held
against brain preservation. There are those today who refuse evidence-based
medical care and their wishes are respected; there is no reason to believe the
development of brain preservation will alter the existing freedom to opt out of
medical care. Finally, there
is the worry that exponential life extension of any kind will not give the
young their chance (Singer 1991). As discussed previously, however, empirical
evidence is suggesting just the opposite. Life-extension technologies are
needed to give the young the same opportunities as the previous generation by
avoiding the economic burden of sustaining a working/retired ratio that is
rapidly approaching one-to-one in industrialized nations (Zhavoronkov
2013). A related worry is the lack of distribution of wealth created by
inheritance. This concern is more political than ethical and can, in principle,
be addressed through legislation (e.g. taxing a certain percentage of a
personŐs wealth when they are preserved). Currently, cryogenically frozen human
beings are treated as anatomical donations and have no rights. Clearly this
will become increasingly unacceptable as the evidence for brain preservation
grows and the feasibility for WBE increases. This does not mean we must treat
those in suspension as if nothing has changed legally. For example, it has been
proposed that we could legislate just how much wealth those in a preserved state
could choose to have in a trust fund for when they are revived, while the rest
of their money could be treated as inheritance (Sandberg 2014). Thus these
issues do not seem insurmountable. Conclusion We have seen
that there is little reason to fear progress in brain preservation
technologies; rather, there is every reason to be optimistic. Chemical brain
preservation is not currently an option, but it is extremely likely that within
only a few years whole brain preservation protocols
with strong scientific support in favor of connectome
preservation will be available for large mammalian brains. When this happens,
chemical brain preservation should be viewed as a life-saving medical
procedure. In another decade, if whole brain emulation is successfully demonstrated
in mice, then there will be overwhelming evidence that chemical brain
preservation is a reversible and life-saving medical procedure. It would
require an extraordinary amount of evidence showing harm to society to outweigh
an individualŐs autonomy to choose this procedure if it is available, and no
such evidence exists. The public is becoming more and more sophisticated in
understanding these technologies, and the old arguments against life extension
are becoming increasingly stale. In his struggle to gain acceptance for anti-aging
research Aubrey de Grey has noted: I mean only that the evolution of our
morality over time seems – for whatever reason – reliably to follow
a course of increasing internal consistency, and, in particular, when deviations
from this consistency become too stark to ignore, ethical opinions that are
more central tend to survive at the expense of less central ones. (de Grey 2005, 660) Thus
with ever increasing advances in science, anti-aging research and life extension
will be seen by the public as increasingly acceptable. Brain preservation and
whole brain emulation will likely take longer to become widely accepted, yet
once whole brain emulations become routine in animals it will become
increasingly inconsistent to argue against the use of these technologies to
preserve life. The
hypothesis that we are our connectome is a
revolutionary idea that will take time to assimilate. Yet each day our
scientific understanding of the brain grows, and there is no turning back from
this knowledge. We need to learn from the tragedy of mainstream scienceŐs
abandonment of the cryonics community. Brain preservation and whole brain
emulation need to remain within the respected domains of mainstream scientific
research, and organizations such as the Brain Preservation Foundation have
recruited a wide range of highly respected scientific advisors to insure the
scientific communityŐs involvement (Brain Preservation Foundation –
People n.d.). It would be a great tragedy not to take
advantage of these technologies when they become available. It is time to
remove the taboo from brain preservation technologies (including cryonics) and
support a major research investment in these procedures. Notes 1. Mary Shelley,
the author of Frankenstein, wrote a
short story in 1826 entitled ŇRoger Dodsworth: The Reanimated EnglishmanÓ about a man
being revived after being frozen in the Alps. 2. The story
of modern cryonics is a tragic one of a legitimate scientific endeavor being
abandoned by the scientific community (Darwin
1991; Cave 2012). A few brave souls continue to pursue cryonics, and
this medical procedure is available today through two institutions (see Alcor n.d.; Cryonics Institute n.d.). 3. Newer forms
of cryonics use a process called vitrification (Pichugin, Fahy, and Morin 2006; Fahy et al. 2009). Vitrification
employs low temperatures and cryoprotectants to turn
tissue into a glass-like state where decay is extremely slow. It is also
possible to develop hybrid procedures involving elements of both cryonics and
chemical brain preservation (McIntyre and Fahy 2015). 4. The birth
rate in the United States is also down, but the population is stable largely
due to immigration. References Ad Hoc
Committee on Medical Ethics. 1984. American College of Physicians. American
College of Physicians Ethics Manual. Part II: Research, Other Ethical
Issues. Annals of Internal Medicine 101(2): 263–67. Alcor. n.d.
Alcor Life Extension website. http://www.alcor.org/ (accessed February 26, 2016). Beauchamp T.,
and J. Childress. 1977. Principles of biomedical ethics. New York:
Oxford University Press. Blow C.M. 2013.
Radical life
extension. New York Times.
August 7. http://www.nytimes.com/2013/08/08/opinion/blow-radical-life-extension.html?_r=0 (accessed February 26, 2016). Bolte, R.G., P.G. Black, J.K. Thorne, and H.M.
Corneli. 1988. The use of extracorporeal rewarming in
a child submerged for 66 minutes. Journal of the American Medical Association 260: 377–79. Bostrom, N. 2005a. The fable of the
dragon-tyrant. Journal of
Medical Ethics 31(5): 273–77. Bostrom, N. 2005b. Recent developments in the ethics, science,
and politics of life-extension. Ageing Horizons 3 (September/October):
28–33. Bostrom, N. 2006. A history of transhumanist
thought. Journal of Evolution and
Technology 14(1) (June): 1–25. http://jetpress.org/volume14/bostrom.pdf (accessed February 26, 2016). Brain
Preservation Foundation – Tech Prize. n.d.
Information regarding Brain Preservation Prize. http://www.brainpreservation.org/tech-prize/ (accessed February 26, 2016). Brain
Preservation Foundation – Announcement. n.d.
Small Mammal BPF Prize Winning Announcement http://www.brainpreservation.org/small-mammal-announcement/ (accessed February 26, 2016). Brain
Preservation Foundation – People. n.d. BPF
Advisory Board. http://www.brainpreservation.org/content/advisors (accessed February 26, 2016). Brain
Preservation Foundation – Our Vision. n.d.
Bill of Preservation Rights. http://www.brainpreservation.org/preservation-rights/ (accessed February 26, 2016). Cave, S. 2012. Immortality:
The quest to live forever and how it drives civilization. New York: Random House. Cerullo, M.A. 2015. Uploading and branching identity. Minds and Machines 25(1): 17–36. http://link.springer.com/article/10.1007%2Fs11023-014-9352-8 (accessed
February 26, 2016). Cryonics
Institute n.d. Cryonics Institute website. http://www.cryonics.org/ (accessed February 26, 2016). Cutas, D., and J. Harris. 2007. The ethics of
ageing, immortality and genetics. In Principles
of health care ethics, 2nd ed., ed.
R. Ashcroft, A. Dawson, H. Draper, and J. McMillan, 797–802. Chichester, UK: Wiley. de Grey, A.D.N.J. 2005. Life
extension, human rights, and the rational refinement of repugnance. Journal of Medical Ethics 31: 659–63. Darwin, M. 1991. Cold war: The
conflict between cryonicists and cryobiologists.
Cryonics. Orig. pub. in three parts: 12(6) (June): 4–14; 12(7) (July):
2–8; 12(8) (August): 5–7. Available
online via Cryonics Magazine archive: http://www.alcor.org/CryonicsMagazine/archive.html (accessed February 26, 2016). Denk, W., and H. Horstmann.
2004. Serial block-face scanning electron microscopy to reconstruct
three-dimensional tissue nanostructure. PLoS Biology
2(11): e329. Drexler, K.E.
1987. Engines of creation: The coming era
of nanotechnology. London: Anchor. Eth,
D., J. Foust, and B. Whale.
2013. The prospects of whole brain emulation within the next half-century. Journal
of Artificial General Intelligence 4(3): 130-52. Eliasmith, C., T.C. Stewart, X. Choo, T. Bekolay, T. DeWolf, Y. Tang, and D. Rasmussen. 2012. A large-scale
model of the functioning brain. Science 338: 1202–1205. Fahy, G.M., B. Wowk,
R. Pagotan, A. Chang, J. Phan,
B. Thomson, and L. Phan. 2009. Physical and
biological aspects of renal vitrification. Organogenesis 5(3): 167–75. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781097/ (accessed February 26, 2016). Fukuyama,
F. 2002. Our posthuman
future: Consequences of the biotechnology revolution. New York: Picador. Gallois, A. 2005–2011. Identity
over time. Stanford Encyclopedia of Philosophy
(Summer 2012 Edition), ed. E.N. Zalta. http://plato.stanford.edu/archives/sum2012/entries/identity-time/ (accessed February 26, 2016). Gitlin, J.M. 2013. Calculating
the economic impact of the Human Genome Project. National Human Genome Research
Institute. https://www.genome.gov/27544383 (accessed February 26, 2016). Glannon, W. 2002. Identity, prudential
concern, and extended lives. Bioethics 16(3): 266–83. Hayat, M.A. 2000. Principles
and techniques of electron microscopy: Biological applications. Cambridge:
Cambridge University Press. Hayworth, K.[J.] 2010. Killed by bad philosophy: Why brain preservation
followed by mind uploading is a cure for death. Brain
Preservation Foundation. http://www.brainpreservation.org/wp-content/uploads/2015/08/killed_by_bad_philosophy.pdf (accessed February 26, 2016). Hayworth, K.J.
2012. Electron imaging technology for whole brain neural
circuit mapping. International
Journal of Machine Consciousness 4(1):
87–108. Hayworth, K.J.,
C.S. Xu, Z. Lu, G.W. Knott, R.D. Fetter, J.C. Tapia,
J.W. Lichtman, and H.F. Hess. 2015. Ultrastructurally smooth thick partitioning and volume
stitching for large-scale connectomics. Nature Methods 12(4):
319–22. Helmstaedter, M., K.L. Briggman, S.C. Turaga, V. Jain,
H.S. Seung, and W. Denk. 2013. Connectomic
reconstruction of the inner plexiform layer in the
mouse retina. Nature
500: 168–74. Honey,
C., J.P. Thivierge, and O. Sporns. 2010. Can structure predict function in
the human brain? NeuroImage 52: 766–76. Horrobin, S. 2005. The ethics of aging intervention and
life-extension. In Aging
interventions and therapies, ed. S. Rattan, 1–28. Singapore: World
Scientific Publishers. Human
Brain Project. n.d. Human Brain Project website. https://www.humanbrainproject.eu (accessed February 26,
2016). Human Brain
Project SP1. n.d. Human
Brain Project Strategic Mouse Brain Data. https://www.humanbrainproject.eu/strategic-mouse-brain-data (accessed
February 26, 2016). Human Brain
Project SP2. n.d. Human
Brain Project Strategic Human Brain Data. https://www.humanbrainproject.eu/strategic-human-brain-data (accessed
February 26, 2016). Jain,
V., H.S. Seung, and S.C. Turaga. 2010. Machines that learn to segment
images: A crucial technology for connectomics. Current Opinion in
Neurobiology 20: 653–66. Kass, L. 2001. LŐChaim
and its limits: Why not immortality? First Things 11: 17–24. Kass, L. 2003. Ageless bodies, happy souls:
Biotechnology and the pursuit of perfection. New Atlantis 1 (Spring): 9–28. Kevles, D. 1999. Life on the far side
of 150. New York Times, March
16. http://www.nytimes.com/1999/03/16/opinion/life-on-the-far-side-of-150.html (accessed February 26, 2106) Knott, G., H. Marchman, D. Wall, and B. Lich. 2008. Serial section
scanning electron microscopy of adult brain tissue using focused ion beam
milling. Journal of Neuroscience 28(12):
2959–2964. Kurzweil, R. 2005. The
Singularity is near: When humans transcend biology. New York: Viking. Lewis,
D. 1976. Survival and identity. In The Identities of Persons, ed. A.O. Rorty, 17–40. Berkeley: University of
California Press. Marblestone, A.H, and E.S. Boyden. 2014. Designing
tools for assumption-proof brain mapping. Neuron 83(6): 1239–1241. Mardis, E.R. 2011. A decadeŐs
perspective on DNA sequencing technology. Nature
470: 198–203. Markram, H. The Blue Brain Project.
Nature Reviews Neuroscience 7(2):153–60. Masci, D. 2013.To count our days: The scientific and ethical dimensions of radical life
extension. Pew Research Center.
August 16. http://www.pewforum.org/files/2013/08/Life-Extension-Essay.pdf (accessed
February 26, 2016). McIntyre, R., and
G. Fahy. 2015 Aldehyde-stabilized cryopreservation. Cryobiology 71(3): 448–58. Merkle, R. 1992. The technical
feasibility of cryonics. Medical Hypotheses 39: 6–16. Metzker, M. 2010. Sequencing technologies – the next
generation. Nature Genetics 11: 31–46.
Mikula, S., and
W. Denk. 2015. High-resolution
whole-brain staining for electron microscopic circuit reconstruction. Nature Methods 12(6): 541–46. Mishchenko, Y. 2009. Automation
of 3D reconstruction of neural tissue from large volume of conventional serial
section transmission electron micrographs. Journal
of Neuroscience Methods 176(2):
276–89. Moen, O.M. 2015. The case for cryonics. Journal of Medical Ethics. Published online
first February 25. doi:10.1136/medethics-2015-102715. http://jme.bmj.com/content/early/2015/02/25/medethics-2015-102715 (accessed February 26, 2016). Morgan, S.,
and M. Taylor. 2006. Low fertility at
the turn of the twenty-first century. Annual Review of Sociology 1(32):
375–99. National
Conference of Commissioners on Uniform State Laws. 1980. Uniform Determination of Death Act. http://pntb.org/wordpress/wp-content/uploads/Uniform-Determination-of-Death-1980_5c.pdf (accessed February 26, 2016). Olson, C. 1988. A possible cure for death. Medical Hypotheses 26: 77–84. Palay, S.L., S.M. McGee-Russell, S. Gordon,
and M.A. Grillo. 1962. Fixation of neural tissues for
electron microscopy by perfusion with solutions of osmium tetroxide. Journal of Cell Biology
12: 385–410. Parfit, D. 1984. Reasons and persons.
Oxford: Clarendon Press. Pichugin, Y., G. Fahy,
and R. Morin. 2006. Cryopreservation of rat hippocampal slices by vitrification. Cryobiology 52: 228–40. Pijnenburg, M.A.M., and C. Leget.
2006. Who wants to live forever? Three arguments against extending the human lifespan. Global Medical Ethics 33(10):
585–87. PresidentŐs
Council on Bioethics.
2003. Beyond therapy: Biotechnology and the pursuit of human improvement. Washington, DC: Dana Press. Rae, M.J,
R.N. Butler, J. Campisi, A.D.N.J. de Grey, C.E.
Finch, M. Gough, G.M. Martin, J. Vijg, K.M. Perrott, and B.J. Logan. 2010. The demographic and
biomedical case for late-life interventions in aging. Science Translational Medicine 2(40): 40cm21. Raj,
A. 2014. Soon, it
will cost less to sequence a genome than to flush a toilet – and that
will change medicine forever. Business
Insider. October 3. http://jme.bmj.com/content/early/2015/02/25/medethics-2015-102715 (accessed February 26, 2016). Rantanen, R. 2013. Issues in the debate on the ethics
of considerable life extension. Res Cogitans 1: 34–51. Samuel, L.
2013. Death, American style: A cultural history of dying in America.
Plymouth, UK: Rowman & Littlefield. Sandberg,
A., and N. Bostrom. 2008. Whole Brain Emulation: A roadmap. Future of
Humanity Institute, Oxford University. http://www.fhi.ox.ac.uk/brain-emulation-roadmap-report.pdf
(accessed February 26, 2016). Sandberg,
A. 2013. Feasibility of whole brain emulation. In Theory
and philosophy of artificial intelligence, ed. V.C. Mller, 251–64. Berlin: Springer. Sandberg,
A. 2014. Ethics of brain emulations. Journal
of Experimental & Theoretical Artificial Intelligence 26(3): 439–57. http://www.tandfonline.com/doi/pdf/10.1080/0952813X.2014.895113 (accessed
February 26, 2016). Seung, H.S. 2011. Towards functional connectomics. Nature 471:170–72. Seung, [H.]S. 2013. Connectome: How the brainŐs wiring makes us who we are.
New York: Houghton Mifflin Harcourt. Singer, P.
1991. Research into aging: Should it be guided by the
interests of present individuals, future individuals, or the species? In
Life span extension: Consequences and
open questions, ed. F. Ludwig,
132–45. New York: Springer. Sporns, O., G. Tononi, and R. K. 2005. The human tterconnectome:
A structural description of the human brain. PLoS
Computational Biology
1(4): e42. http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.0010042 (accessed February 26, 2016). Thomson,
H. 2014. Gunshot victims to be suspended between life and
death. New Scientist 2962
(March 29): 8–9. Van Horn, J.D., and A.W. Toga. 2014. Human
neuroimaging as a Ňbig dataÓ science. Brain Imaging Behavior 8(2):
323–31. Whetstine, L., S. Streat,
M. Darwin, D. Crippen. 2005. Pro/con ethics debate:
When is dead really dead? Critical Care
9: 538–42. Wiley, K.
2014. A taxonomy and metaphysics of mind-uploading. Electronic ed. Seattle: Humanity+ Press
and Alautun Press. Wilson, C. 2004. Fertility below replacement level. Science 304: 207–209. Yang,
G., F. Pan, and W. Gan. 2009. Stably maintained dendritic spines
are associated with lifelong memories. Nature 462(17): 920–25. Yook, C., S. Druckmann, and H.
Kim. 2013. Mapping mammalian synaptic connectivity. Cellular and Molecular Life Sciences 70: 4747–4757. Zador, A.M., J. Dubnau, H.K. Oyibo, H. Zhan, G.
Cao, and I.D. Peikon. 2012. Sequencing the connectome.
PLoS Biology 10(10): e1001411. http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1001411 (accessed February 26, 2016). Zhavoronkov, A. 2013. The ageless generation: How advances in biomedicine will transform the global economy. New York: Palgrave Macmillan. |